{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:30:32Z","timestamp":1785148232330,"version":"3.55.0"},"reference-count":21,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Enterococcus species are gram-positive organisms that are among the most prevalent causes of bacteremia with a urinary source. Combination therapy is considered for deep-seated enterococcal infections due to the occasionally poor bactericidal activity of cell wall\u2013active agents, high failure rates, and synergistic activity. The use of daptomycin and linezolid as monotherapy or as combination therapy with \u03b2-lactams or aminoglycosides is well described in the literature; however, the efficacy of daptomycin and linezolid combination therapy is less clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective single-chart review and single-database narrative literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We describe a 60-year-old man with persistent ampicillin-susceptible Enterococcus faecalis bacteremia secondary to a right ureteric stone. His management was complicated by a suspected anaphylactic reaction shortly after receiving vancomycin and ceftriaxone that progressed after receiving ampicillin and cefazolin, as well as delayed source control due to safety concerns withholding anticoagulation for concurrent high-burden bilateral pulmonary emboli, ultimately resulting in persistent bacteremia. His bacteremia cleared with combination therapy of daptomycin 10 mg\/kg intravenously daily and linezolid 600 mg orally every 12 hours. A review of the literature of Ovid MEDLINE from 2000 to July 16, 2025, revealed limited reported use of combination daptomycin and linezolid for the microbiologic cure of enterococcal infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The bacteremia cleared with combination daptomycin and linezolid therapy on day 9 of admission, prior to achieving source control with nephrostomy tube insertion 2 days later. The patient made a complete recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3138\/jammi-2025-0039","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:57:18Z","timestamp":1778522238000},"page":"205-214","source":"Crossref","is-referenced-by-count":1,"title":["Daptomycin and linezolid salvage therapy for persistent ampicillin-susceptible\n                    <i>Enterococcus faecalis<\/i>\n                    bacteremia in a patient with possible anaphylaxis to \u03b2-lactam and glycopeptide antimicrobials: A case report"],"prefix":"10.3138","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8738-2805","authenticated-orcid":true,"given":"Nam","family":"Phuong","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhonna","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda X","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Messieh","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1548-4410","authenticated-orcid":true,"given":"Moran","family":"Drucker Iarovich","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-0769","authenticated-orcid":true,"given":"Udi","family":"Blankstein","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-7701","authenticated-orcid":true,"given":"Adam S","family":"Komorowski","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada"},{"name":"Research Institute of St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"key":"r1","volume-title":"CLSI M100: Performance Standards for Antimicrobial Susceptibility Testing","author":"Mathers AJ","year":"2025","edition":"35"},{"issue":"4","key":"r2","doi-asserted-by":"crossref","first-page":"e0242921","DOI":"10.1128\/jcm.02429-21","volume":"60","author":"Verway M","year":"2022","journal-title":"J Clin Microbiol"},{"key":"r3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jgar.2022.05.003","volume":"29","author":"Bussini L","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"r4","doi-asserted-by":"crossref","first-page":"116609","DOI":"10.1016\/j.diagmicrobio.2024.116609","volume":"111","author":"K\u0131ymaz Y\u00c7","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"r5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"Hollenbeck BL","year":"2012","journal-title":"Virulence"},{"issue":"2","key":"r6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/cid\/ciy064","volume":"67","author":"Beganovic M","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"r7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/antibiotics14050522","volume":"14","author":"Radford-Smith DE","year":"2025","journal-title":"Antibiotics"},{"key":"r8","volume-title":"Product Monograph Including patient medication Information APO-Linezolid","author":"Drug and Health Product Register","year":"2024"},{"issue":"1","key":"r9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","volume":"73","author":"Heidary M","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"r10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","volume":"61","author":"Britt NS","year":"2015","journal-title":"Clin Infect Dis"},{"key":"r11","volume-title":"Daptomycin Breakpoints for Enterococci","author":"Humphries RM","year":"2019"},{"issue":"2","key":"r12","doi-asserted-by":"crossref","first-page":"e0005922","DOI":"10.1128\/cmr.00059-22","volume":"26","author":"Cairns KA","year":"2023","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"r13","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/AAC.47.12.3789-3794.2003","volume":"47","author":"Wagenlehner FM","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"r14","doi-asserted-by":"crossref","first-page":"205031212097074","DOI":"10.1177\/2050312120970743","volume":"8","author":"Pontefract BA","year":"2020","journal-title":"Sage Open Medicine"},{"issue":"4","key":"r15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jgar.2014.09.004","volume":"2","author":"Entenza JM","year":"2014","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"r16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4081\/itjm.2023.1617","volume":"17","author":"Coppola MG","year":"2023","journal-title":"Ital J Med"},{"issue":"2","key":"r17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","volume":"56","author":"Sakoulas G","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"r18","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1345\/aph.1P333","volume":"44","author":"Le J","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"1","key":"r19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/IPC.0b013e3181e85dcc","volume":"19","author":"Lee DH","year":"2011","journal-title":"Infect Dis Clin Pract"},{"issue":"5","key":"r20","doi-asserted-by":"crossref","first-page":"106432","DOI":"10.1016\/j.ijantimicag.2021.106432","volume":"58","author":"Russo A","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"r21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jac\/dkaf055","volume":"80","author":"Serapide F","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2025-0039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:55:22Z","timestamp":1782748522000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2025-0039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"alternative-id":["10.3138\/jammi-2025-0039"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2025-0039","relation":{},"ISSN":["2371-0888"],"issn-type":[{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}